Q2i’s PARCA Technology Moves to Phase II of National Institutes of Health (NIH) Clinical Trial to Further Evaluate Its Efficacy in Increasing Community Supervision Success

BOSTON, Jan. 22, 2025 /PRNewswire/ — The Probation and Reentry Coach Application (PARCA), developed by Q2i, has successfully completed an NIH Phase I trial and is now transitioning into Phase II. Designed to support individuals navigating probation and parole, PARCA leverages recently…